Prices delayed by at least 15 minutes | Print
Ishares V Public Limited Company ISHRS S&P 500 HEALTH CR SECT ETF USD ACC (IHCU)
Open
1,110.00p
Previous close
1,116.50p
Trade high
1,137.50p
Income frequency
-
Year low
845.37p
Year high
1,137.50p
Replication method
Physical Full
Volume
204,091
Type
ETF
UCITS
Yes
Dividend yield
–
Ongoing charge
0.15
ISIN
IE00B43HR379
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Before investing please read:
Share price
Asset allocation
Top 10 holdings
| Holdings 03/11/2026 | % of assets |
|---|---|
| Eli Lilly and Co | 16.90 |
| Johnson & Johnson | 9.61 |
| AbbVie Inc | 7.57 |
| UnitedHealth Group Inc | 5.44 |
| Merck & Co Inc | 5.35 |
| Thermo Fisher Scientific Inc | 3.87 |
| Amgen Inc | 3.74 |
| Gilead Sciences Inc | 3.11 |
| Abbott Laboratories | 2.84 |
| Pfizer Inc | 2.56 |
Investment objective
The investment objective of the Fund is to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the S&P 500 Capped 35/20 Health Care Index. In order to achieve this investment objective, the investment policy of the Fund is to invest in a portfolio of equity securities that as far as possible and practicable consist of the component securities of the S&P 500 Capped 35/20 Health Care Index, this Fund’s Benchmark Index. The Fund intends to replicate the constituents of the Benchmark Index by holding all the securities comprising the Benchmark Index in a similar proportion to their weightings in the Benchmark Index. In order to replicate its Benchmark Index, this Fund may invest up to 20% of its Net Asset Value in shares issued by the same body. This limit may be raised to 35% for a single issuer when exceptional market conditions apply (as set out in section 4 of Schedule III).
This product is based overseas and is not subject to UK sustainable investment labelling and disclosure requirements. Learn more about SDR.